Ultragenyx Pharmaceutical Inc. (RARE) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

Ultragenyx Pharmaceutical...

NASDAQ: RARE · Real-Time Price · USD
31.82
0.54 (1.73%)
At close: Sep 05, 2025, 3:59 PM
31.82
0.00%
After-hours: Sep 05, 2025, 05:10 PM EDT

Ultragenyx Pharmaceutical Revenue

Ultragenyx Pharmaceutical reported an annual revenue of $560.23M, reflecting a 29.01% growth. For the quarter ending June 30, 2025, Ultragenyx Pharmaceutical generated $166.5M in revenue.
Revenue (ttm)
560.23M
Revenue Growth
29.01%
Price / Sales Ratio
6.8
Revenue / Employee
432.94K
Employees
1,294
Market Cap
3.07B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 560.23M +29.01%
Dec 31, 2023 434.25M +19.52%
Dec 31, 2022 363.33M +3.39%
Dec 31, 2021 351.41M +29.66%
Dec 31, 2020 271.03M +161.32%
Dec 31, 2019 103.71M +101.41%
Dec 31, 2018 51.49M +1871.48%
Dec 31, 2017 2.61M +1863.91%
Dec 31, 2016 133K +Infinity%
Dec 31, 2015 0 n/a
Dec 31, 2014 0 n/a
Dec 31, 2013 0 n/a
Dec 31, 2012 0 n/a
Dec 31, 2011 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.